Observational study on evaluation of glycaemic control in patients using a modern insulin - NovoRapid (insulin aspart), NovoMix 30 (biphasic insulin aspart) or Levemir (insulin detemir) - for treatment of diabetes mellitus.
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Insulin aspart; Insulin aspart/insulin protamine aspart; Insulin detemir
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms COMMIT-CLEAN-SWITCH
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 19 Apr 2011 Planned end date changed from 1 Apr 2011 to 1 May 2010 as reported by ClinicalTrials.gov.
- 19 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.